| Literature DB >> 23167543 |
Clifford G Clark1, Christopher C R Grant, Frank Pollari, Barbara Marshall, Jason Moses, Dobryan M Tracz, Matthew W Gilmour.
Abstract
BACKGROUND: Prophages of enteric bacteria are frequently of key importance for the biology, virulence, or host adaptation of their host. Some C. jejuni isolates carry homologs of the CJIE1 (CMLP 1) prophage that carry cargo genes potentially involved in virulence. Possible role(s) of CJIE1 homologs in the biology and virulence of C. jejuni were therefore investigated by using in vitro cell culture assays and by assessing the association of C. jejuni isolates with and without these prophages with patients' symptoms, with source, and with clonal lineages within the C. jejuni population.Entities:
Mesh:
Year: 2012 PMID: 23167543 PMCID: PMC3519530 DOI: 10.1186/1471-2180-12-269
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
PCR primers and conditions used in this study to verify the presence of genes associated with strains NCTC 11168 and RM1221 in isolates 00–2425, 00–2426, 00–2538, and 00-2544
| cj0032 | F | TTTAAAGGCCAAGATAGAA | 512 | 48.3 |
| | R | GCGTAAAGAAATAGCAAGTT | | |
| cj0138 | F | GAAGGCGGGGTAAATCT | 151 | 46.1 |
| | R | TTGCAAAATGTTCTATCTT | | |
| cje0302 | F | TCCTTTGATGCTTTCTAA | 137 | 43.8 |
| | R | GTCCTATACTAACTCCACTT | | |
| cj0424 | F | TTTGTAGTTTAATTGCGATGTTGT | 346 | 50.1 |
| | R | AGTAGTTTTCCCTTTGCTCTCA | | |
| cj0589 | F | ATGGGGCTTTATTAGTTATT | 547 | 46.6 |
| | R | TCGCTTGATCTTACACCT | | |
| cj0628 | F | ATCAAAACAATTCGGCAACTT | 455 | 51.5 |
| | R | ACTTCGATTCAATATACCAACACC | | |
| cj0780 | F | TGGCGTTAAAGCGGGTGATA | 492 | 52.8 |
| | R | CCTGGTTTTGGGTTGATAGTCTT | | |
| cj1158 | F | TTTAAACATATCATAAGCACCTTTTT | 107 | 46.0 |
| | R | GCTATTACTTCTCCCGTGATTTAT | | |
| cj1202 | F | ATCAAAAATCTTCATGCTATCTTA | 434 | 48.8 |
| | R | TTATCTGTTCCTGCATTTACCTTA | | |
| cj1218 | F | AATTCTTTCGACTTCTTCC | 317 | 46.6 |
| | R | ATTTTATCGGCACACTTGA | | |
| cj1318/ | F | GGAGGAAATGGAAAAGTTGAA | 477 | 48.2 |
| | R | AAATTGAGTACGCAGAGGTTGT | | |
| cj1333 | F | TTTTGGGGAATTTGATAAGGA | 460 | 44.6 |
| | R | ACAGTTGTAGGTGGTAATA | | |
| cj1463 | F | AAAGCCTTAAAAGAACAAACCAA | 174 | 48.8 |
| | R | TGAAAAACCCATACCTCCACTTA | | |
| cj1622 | F | ACGCCTTACATGAGTTTAT | 438 | 48.4 |
| | R | TAGGGCAATCTTTTCTTATG | | |
| cj1729 | F | CCATCTGCCGTTACTACTACTTTT | 441 | 52.2 |
| R | ACAGGCTGGAACACCGACTATTA |
The “cj” locus designations refer to genes present in NCTC 11168, while the “cje” locus designation refers to a gene in RM1221.
Figure 1Growth curves for isolates.A. isolate 00-2425, with prophage vs. 00-2426, without prophage; B. isolate 00-2538, with prophage vs. 00-2426, without prophage; C. isolate 00-2544, with prophage vs. 00-2426, without prophage. Each set of paired growth curves was done during the same week from independent cultures as summarized in the Materials and Methods
Figure 2Comparison of the adherence and invasion of test isolates and controls strains.A. adherence as % of input, B. invasion expressed as the % invaded divided by the total bacteria adherent. Experimental replicates: 81-176, n = 10; 00-2538, n = 9; 00-2544, n = 5; 00-2425, n = 8; 00-2426, n = 6; E. coli Top 10 strain, n = 10
Comparison of three separate adherence and invasion experiments
| | | | | | | |
| 81-176 (+ve control) | (5.2 ± 0.8) × 107 | (3.3 ± 1.0) × 106 | 6.5 | (6.3 ± 2.2) × 105 | 1.22 | 18.8 |
| 00-2544 (+ prophage) | (3.7 ± 0.2) × 107 | (3.8 ± 1.2) × 105 | 1.0 | (2.7 ± 1.1) × 104 | 0.07 | 7.0 |
| 00-2538 (+ prophage) | (3.7 ± 0.9) × 107 | (8.7 ± 0.1) × 105 | 2.4 | (2.0 ± 0.8) × 105 | 0.54 | 23.0 |
| 00-2425 (+ prophage) | (4.1 ± 0.4) × 107 | (6.4 ± 0.8) × 105 | 1.6 | (2.0 ± 0.4) × 105 | 0.48 | 31.9 |
| 00-2426 (− prophage) | (4.1 ± 0.1) × 107 | (1.2 ± 0.4) × 105 | 0.3 | (1.0 ± 0.7) × 103 | 0.002 | 0.8 |
| (2.2 ± 0.1) × 107 | (5.2 ± 1.0) × 105 | 2.3 | (9.5 ± 0.2) × 103 | 0.042 | 1.8 | |
| | | | | | | |
| 81-176 (+ve control) | (2.1 ± 0.5) × 107 | (3.5 ± 1.2) × 105 | 1.6 | (2.2 ± 0.3) × 105 | 1.04 | 64.3 |
| 00-2544 (+ prophage) | (1.8 ± 0.8) × 107 | (3.5 ± 2.4) × 105 | 1.9 | (6.5 ± 1.5) × 104 | 0.33 | 18.8 |
| 00-2538 (+ prophage) | (3.4 ± 0) × 107 | (3.9 ± 2.3) × 105 | 1.1 | (7.0 ± 0.9) × 104 | 0.20 | 17.9 |
| 00-2425 (+ prophage) | (3.3 ± 0.6) × 107 | (5.6 ± 1.5) × 105 | 1.7 | (8.4 ± 3.5) × 104 | 0.26 | 15.0 |
| 00-2426 (− prophage) | (3.4 ± 0.2) × 107 | (4.0 ± 2.1) × 104 | 0.1 | (8.7 ± 3.3) × 102 | 0.003 | 2.2 |
| (1.8 ± 0.2) × 107 | (1.7 ± 0.9) × 105 | 1.0 | (9.6 ± 1.6) × 103 | 0.055 | 5.7 | |
| | | | | | | |
| 81-176 (+ve control) | (3.4 ± 0.1) × 107 | (1.8 ± 0.3) × 106 | 5.4 | (1.0 ± 0.6) × 105 | 0.30 | 5.6 |
| 00-2544 (+ prophage) | (2.3 ± 0.3) × 107 | (3.6 ± 1.3) × 105 | 1.6 | (4.1 ± 2.0) × 104 | 0.18 | 11.4 |
| 00-2538 (+ prophage) | (3.8 ± 0.4) × 107 | (6.3 ± 2.8) × 105 | 1.7 | (1.3 ± 0.3) × 105 | 0.33 | 20.2 |
| 00-2425 (+ prophage) | (4.3 ± 1.0) × 107 | (1.1 ± 0.2) × 106 | 2.5 | (2.5 ± 1.0) × 105 | 0.58 | 22.8 |
| 00-2426 (− prophage) | (3.8 ± 1.6) × 107 | (1.6 ± 0.3) × 105 | 0.4 | (5.5 ± 6.0) × 102 | 0.001 | 0.35 |
| (2.0 ± 0.01) × 107 | (2.1 ± 0.6) × 105 | 1.1 | (4.9 ± 2.2) × 103 | 0.024 | 2.3 |
Association of the CJIE1 prophage and the CJIE1 prophage carrying ORF 11 with patient symptoms
| Diarrhea | 214/218 (98.2) | 158/162 (97.5) | 16/16 (100) | 15/15 (100) |
| Abdominal pain | 169/204 (83.0) | 127/153 (83.0) | 9/16 (56.3) | 12/15 (80.0) |
| Fever | 134/219 (61.2) | 107/146 (73.3) | 4/16 (25.0) | 6/14 (42.9) |
| Malaise | 127/199 (63.8) | 95/145 (65.5) | 9/16 (56.3) | 9/14 (64.3) |
| Nausea | 113/205 (57.5) | 87/151 (57.6) | 8/16 (50.0) | 9/14 (64.3) |
| Headache | 91/201 (45.3) | 70/142 (49.3) | 7/16 (43.8) | 4/11 (36.4) |
| Bloody diarrhea | 49/145 (33.7) | 33/99 (33.3) | 4/15 (26.7) | 8/14 (57.1) |
| Vomiting | 73/214 (34.1) | 56/157 (35.7) | 3/16 (18.8) | 5/14 (35.7) |
| Duration > 10 days | 33/137 (24.1) | 35/102 (34.3) | 2/10 (20.0) | 3/9 (33.3) |
| Hospitalization | 15/142 (10.6) | 10/125 (6.6) | 1/13 (7.7) | 2/13 (15.4) |
Note that there were different response rates for different questions, resulting in different denominators. “Patients with symptoms” refers to the number of patients having the particular symptom compared with the total number of patients answering the question yes or no on the questionnaire. This column provides data on the overall frequency of symptoms. Isolates for further analysis were not available for all patients answering the comprehensive questionnaire. Data in the section “Association of C. jejuni strain characteristics with symptoms…” contains symptom information from patients from whom isolates were obtained and were typed. The frequencies with which each symptom was associated with the presence of absence of the CJIE1 prophage and also the presence within the CJIE prophage of ORF11 have been compared to determine whether either CJIE1 alone or CJIE1 with ORF11 have any significant effect on patient symptoms compared with absence of the prophage.
Distribution of CJIE1 prophage and ORF 11 according to source and bacterial species
| chicken breast | 113 | 82 (73) | 24 (21) | 7 (6) | |
| | 14 | 7 (50) | 6 (43) | 1 (7) | |
| river water | 14 | 12 (86) | 1 (7) | 1 (7) | |
| human | 244 | 190 (78) | 27 (11) | 27 (11) | |
| | 25 | 17 (68) | 8 (32) | 0 | |
| bovine manure | 33 | 29 (88) | 3 (9) | 1 (3) | |
| swine manure | 4 | 1 (25) | 3 (75) | 0 | |
| | 21 | 21 (100) | 0 | 0 | |
| other non-human | 11 | 9 (82) | 1 (9) | 1 (9) | |
| | 6 | 6 (100) | 0 | 0 | |
| Total | 496 | 381 (77) | 74 (15) | 41 (8) |
Frequency of carriage of CJIE1 prophage and ORF11 within the predominant multi-locus sequence types (ST)
| 8 | 10 | 9/10 (90) | 0 | 1/10 (10) |
| 21 | 25 | 16/25 (64) | 4/25 (16) | 5/25 (20) |
| 42 | 15 | 8/15 (53) | 7 | 0 |
| 45 | 91 | 84/91 (92) | 5/91 (6) | 2/91 (2) |
| 48 | 11 | 8/11 (73) | 0 | 3/11 (27) |
| 50 | 9 | 7/9 (78) | 2/9 (22) | 0 |
| 52 | 7 | 7/7 (100) | 0 | 0 |
| 61 | 7 | 7/7 (100) | 0 | 0 |
| 137 | 2 | 0 | 2/2 (100) | 0 |
| 267 | 8 | 7/8 (88) | 1/8 (12) | 0 |
| 353 | 8 | 7/8 (88) | 1/8 (12) | 0 |
| 429 | 3 | 0 | 3/3 (100) | 0 |
| 459 | 15 | 14/15 (93) | 0 | 1/93 (7) |
| 460 | 9 | 7/9 (78) | 1/9 (11) | 1/9 (11) |
| 508 | 7 | 6/7 (86) | 0 | 1/7 (14) |
| 806 | 8 | 7/8 (88) | 1/8 (12) | 0 |
| 922 | 13 | 13/13 (100) | 0 | 0 |
| 929 | 13 | 13/13 (100) | 0 | 0 |
| 939 | 2 | 0 | 2/2 (100) | 0 |
| 982 | 38 | 27/38 (71) | 5/38 (13) | 6/38 (16) |
| 1068 | 14 | 12/14 (86) | 2/14 (14) | 0 |
| Total | 315 | 259/315 (82) | 36/315 (11) | 20/315 (6) |
Frequency of carriage of CJIE1 prophage and ORF11 within the predominant SVR types
| 2 | 7 | 7/7 (100) | 0 | 0 |
| 5 | 6 | 5/6 (83) | 0 | 1/6 (17) |
| 8 | 13 | 10/13 (77) | 3/13 (23) | 0 |
| 9 | 8 | 7/8 (88) | 1/8 (12) | 0 |
| 11 | 6 | 5/6 (83) | 1/6 (17) | 0 |
| 13 | 12 | 10/12 (83) | 2/12 (17) | 0 |
| 14 | 28 | 26/28 (93) | 1/28 (3.5) | 1/28 (3.5) |
| 16 | 23 | 21/23 (91) | 2/23 (9) | 0 |
| 18 | 16 | 14/16 (88) | 2/16 (12) | 0 |
| 21 | 59 | 55/59 (93) | 2/59 (3.5) | 2/59 (3.5) |
| 22 | 13 | 12/13 (92) | 1/13 (8) | 0 |
| 34 | 18 | 12/18 (67) | 4/18 (22) | 2/18 (11) |
| 36 | 24 | 14/24 (58) | 2/24 (8) | 8/24 (33) |
| 41 | 10 | 9/10 (90) | 1/10 (10) | 0 |
| 42 | 10 | 10/10 (100) | 0 | 0 |
| 45 | 5 | 5/5 (100) | 0 | 0 |
| 46 | 14 | 10/14 (72) | 2/14 (14) | 2/14 (14) |
| 49 | 45 | 34/45 (76) | 5/45 (11) | 6/45 (13) |
| 57 | 8 | 8/8 (100) | 0 | 0 |
| 70 | 8 | 6/8 (75) | 2/8 (25) | 0 |
| 122 | 9 | 9/9 (100) | 0 | 0 |
| 172 | 12 | 8/12 (66) | 2/12 (17) | 2/12 (17) |
| 239 | 13 | 10/13 (77) | 2/13 (15) | 1/13 (8) |
| 245 | 3 | 0 | 3/3 (100) | 0 |
| 359 | 27 | 22/27 (81) | 5/27 (19) | 0 |
| 840 | 8 | 8/8 (100) | 0 | 0 |
Characteristics of clinical isolates used for adherence and invasion assays (from Clark . [[22],[23]])
| 00-2425 | II | 21 | 36 | 1 | O:2 | 125 | 33 | 2 | 2 |
| 00-2426 | II | 21 | 36 | 1 | O:2 | 125 | 33 | 1 | 1 |
| 00-2538 | II | 21 | 36 | 1 | O:2 | 125 | 33 | 11 | 1 |
| 00-2544 | II | 21 | 36 | 1 | O:2 | 125 | 35 | 4 | 1 |
ST, sequence type according to the Oxford MLST scheme; flaA SVR, sequence of the flagellin short variable region DNA sequence according to the Oxford scheme; fla-RFLP, restriction fragment-length polymorphism of the amplified complete flaA locus; HS, heat-stable or Penner serotype; HL, heat-labile or Lior serotype.